Subscribe To
DICE / Are Medical Stocks Lagging DICE Therapeutics (DICE) This Year?
DICE News
By Zacks Investment Research
June 21, 2023
DICE Therapeutics (DICE) Up 37% on Buyout Offer from Eli Lilly
DICE Therapeutics (DICE) is set to be acquired by pharma-giant Eli Lilly (LLY) in an all-cash transaction for $2.4 billion. The transaction will likel more_horizontal
By Zacks Investment Research
June 21, 2023
ETFs to Capitalize on Eli Lilly's Buyout of DICE Therapeutics
Eli Lilly (LLY) has agreed to acquire DICE Therapeutics (DICE) in a cash deal worth approximately $2.4 billion. This strategic move is part of Eli Lil more_horizontal
By The Motley Fool
June 21, 2023
Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event?
Eli Lilly and Dice Therapeutics agreed to a $2.4 billion buyout on Tuesday. Lilly might have landed important new immunology drugs via this deal. more_horizontal
By The Motley Fool
June 20, 2023
Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Know
Lilly plans to buy Dice Therapeutics for $2.4 billion to expand its immunology pipeline. Investors appear to approve of the deal's price tag. more_horizontal
By GuruFocus
June 20, 2023
Shares of Eli Lilly, Dice Therapeutics Gain on Acquisition Announcement
Looking to enhance its product portfolio for immune-related diseases, an area where it has lagged behind the competition, Eli Lilly & Co. ( LLY , Fina more_horizontal
By Investopedia
June 20, 2023
Eli Lilly Buys DICE Therapeutics for $2.4 Billion
Eli Lilly agreed to buy DICE Therapeutics for $2.4 billion. The deal values DICE shares at an almost 40% premium from Friday's close. more_horizontal
By The Motley Fool
June 20, 2023
Why Shares of Dice Therapeutics Are Skyrocketing Tuesday
Lilly is paying a 40% premium for Dice's shares. Dice is a clinical-stage biotech with six programs in its pipeline. more_horizontal
By Stockmarketcom
June 20, 2023
2 Biotech Stocks For Your June 2023 Watchlist
Biotech stocks to watch in the stock market now. more_horizontal